Reported 83,388 shares, up 1,671 (2.0%) from the prior quarter.
Reported value -2.1%; share count 2.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2015-06-30 | 712000 |
| 2015-09-30 | 838000 |
| 2015-12-31 | 820000 |
| 2016-03-31 | 325000 |
| 2016-06-30 | 957000 |
| 2016-09-30 | 1095000 |
| 2016-12-31 | 762000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2016 | Added | 354,543 | +10,093 (2.9%) | < 0.01% | $762,000 | 2017-02-10 | |
| Q3 2016 | Added | 344,450 | +236 (0.1%) | < 0.01% | $1,095,000 | 2016-11-08 | |
| Q2 2016 | Added | 344,214 | +261,753 (317.4%) | < 0.01% | $957,000 | 2016-08-10 | |
| Q1 2016 | Reduced | 82,461 | -927 (-1.1%) | < 0.01% | $325,000 | 2016-05-10 | |
| Q4 2015 | Added | 83,388 | +1,671 (2.0%) | < 0.01% | $820,000 | 2016-02-11 | |
| Q3 2015 | Added | 81,717 | +43,264 (112.5%) | < 0.01% | $838,000 | 2015-11-13 | |
| Q2 2015 | New | 38,453 | +38,453 (0.0%) | < 0.01% | $712,000 | 2015-08-07 |
Who else reported the position
51 managers reported ATYR PHARMA INC for Q4 2015.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| FMR LLC | Added | 3,547,261 | +1,369 | < 0.01% | $34,870,000 | 3 qtrs |
| BAKER BROS ADVISORS LP | Unchanged | 2,335,125 | 0 | 0.19% | $22,954,000 | 3 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Reduced | 1,169,007 | -15,100 | < 0.01% | $11,491,000 | 3 qtrs |
| EcoR1 Capital LLC | Reduced | 790,462 | -50,000 | 2.44% | $7,770,000 | 3 qtrs |
| BlackRock Fund Advisors | Added | 443,937 | +281,516 | < 0.01% | $4,364,000 | 3 qtrs |
| Rock Springs Capital Management LP | Added | 415,196 | +26,200 | 0.31% | $4,081,000 | 3 qtrs |
| JPMorgan Chase & Co | Added | 375,750 | +11,577 | < 0.01% | $3,694,000 | 3 qtrs |
| Alyeska Investment Group L P | Added | 309,062 | +124,885 | 0.03% | $3,038,000 | 3 qtrs |
| Magnetar Financial LLC | Reduced | 186,299 | -168,360 | 0.02% | $1,831,000 | 3 qtrs |
| VANGUARD GROUP INC | Added | 172,919 | +20,308 | < 0.01% | $1,699,000 | 3 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2015
- Filed
- February 11, 2016
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 78,332
- Shared
- 0
- None
- 5,056
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.